Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.50 – $1.92
24% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $10.93B | $11.19B | $11.55B | $12.78B | $13.93B | $13.05B | $14.35B |
| Cost of revenue | $3.70B | $4.01B | $4.30B | $5.07B | $5.45B | $5.14B | $5.39B |
| Gross profit | $7.23B | $7.19B | $7.25B | $7.70B | $8.47B | $7.92B | $8.96B |
| Gross margin | 66.2% | 64.2% | 62.8% | 60.3% | 60.8% | 60.6% | 62.4% |
| R&D | $163.7M | $139.0M | $144.0M | $158.2M | $206.1M | $243.0M | $210.6M |
| Operating income | $1.85B | $1.78B | $1.51B | $1.61B | $1.83B | $1.57B | $1.69B |
| EBITDA | $2.04B | $2.13B | $1.42B | $1.87B | $2.04B | $1.37B | $1.56B |
| Net income | $1.01B | $1.14B | $508.5M | $611.8M | $581.8M | −$53.7M | $191.1M |
| Net margin | 9.2% | 10.2% | 4.4% | 4.8% | 4.2% | -0.4% | 1.3% |
| EPS (diluted) | 1.55 | 1.76 | 0.79 | 0.95 | 0.90 | -0.08 | 0.30 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $16.5B | $1.13 | $1.05–$1.19 | 1 |
| 2027 | $18.1B | $1.44 | $1.35–$1.52 | 1 |
| 2028 | $19.9B | $1.77 | $1.65–$1.87 | 1 |
Forward consensus · source: Financial Modeling Prep
HEALTH & HAPPINESS ORD
No one on the platform currently holds BTSDF.
No tracked institution reports a position in BTSDF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-21 | $0.1600 | 2026-07-17 |
| 2025-09-11 | $0.1900 | 2025-10-17 |
| 2025-05-19 | $0.0500 | 2025-07-09 |
| 2024-09-12 | $0.3000 | 2024-10-15 |
| 2024-05-16 | $0.1800 | 2024-07-10 |
| 2023-09-05 | $0.4400 | 2023-10-10 |
No one on the platform has traded BTSDF yet.
| +0.00% |
| $650M |
| — |
| JWLLFJamieson Wellness Inc. | $28.92 | +0.00% | $1.2B | — |
| SGPPYThe SPAR Group Ltd | $3.15 | +0.00% | $607M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.9× earnings vs its 1.8× historical median P/E.
Fair value ≈ $3.24 · price $1.60 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.